Body Vision Medical, a medical device company specializing in augmented real-time imaging, has developed the Body Vision Solution, a software-driven intra-body navigation platform.

Seamlessly integrated into the flow of existing operating room procedures, Body Vision provides accurate real-time visualization, navigation and tools to access soft tissue targets such as early-stage cancerous lesions during diagnostic and treatment procedures.


Today, soft tissue lesions are diagnosed and treated through complex surgical procedures, with high risk to patients, long recovery periods and high costs.

Although the standard of care includes many imaging platforms to guide physicians pre-operatively, they remain blind during procedures in the operating room without real-time guidance, a crucial element for minimally invasive procedures.




Body Vision’s accurate real-time visualization and navigation operates inside the existing flow of operating room procedures, allowing physicians to maintain their protocol for diagnosing and treating patients, while adding the revolutionary benefit of real-time visualization.

The LungVision suite, an intra-body navigation system combined with a disposable navigation catheter, provides an affordable and effective real-time solution for early-stage lung cancer diagnostic procedures.

LungVision received FDA clearance in May 2017 and is the first application-specific implementation of the Body Vision platform to enter the clinical market.


Utilizing a sophisticated augmented reality approach, Body Vision Medical has developed a medical platform technology for accurate real-time navigation, allowing reliable diagnostic and treatment procedures for radiolucent soft tissue lesions. Body Vision software, hardware and disposable tools help surgeons plan, visualize, and track their navigation during these procedures.

A visual feature of Body Vision technology is synergistic imaging, merging intraoperative 2D with 3D pre-operative high-resolution imaging such as CT.

Body Vision developed unique technology that combines the intelligence of navigation with the simplicity of fluoroscopy.
It enables effective localization and enhanced biopsy of lung lesions, upgrading the standard methods used in our daily practice.”
— D. Kyle Hogarth, MD, FCCP Associate Professor of Medicine, Director of Bronchoscopy at the University of Chicago and one of the first LungVision users in North America

LungVision technology has distinct advantages over current electromagnetic navigation approach and has offered the possibility of increased diagnostic yield. In our studies we have found striking accuracy compared to cone-beam CT. Furthermore, LungVision offers dynamic target tracking to compensate for respiratory motion. Real-time imaging will always be superior to any virtual technology and will ultimately be imperative in the future application of ablative energy for therapeutics.”
— Michael Pritchett, MD, a pulmonologist at Pinehurst Medical Clinic and the Director of the Chest Center of the Carolinas at FirstHealth Moore Regional Hospital in Pinehurst, NC

LungVision shows good technical feasibility as a guidance and localization modality for pulmonary lesions, and may prove an alternative to electromagnetic navigation bronchoscopy. One tangible benefit of the system in early testing is in its ease of set up and straight forward real time guidance. Further studies are currently underway to determine diagnostic accuracy of this technology.”
— Sean Stoy, MD, University of Chicago Medical Center, winner of the 2017 American Thoracic Society Scholarship award for his research on the LungVision system



Minimally invasive real-time lesion localization for navigation, biopsy and therapeutics


Seamless integration with a wide variety of clinical environments and tools



Significant reduction of procedure time and costs